Based on above results, it’s suggested that in terms of the tumor immune microenvironment, ASF1B expression levels were significantly negatively correlated with the immune score in BRCA, LUSC, STAD, UCEC while significantly positively correlated with the immune score in KIRC. Here, ASF1B is linked to neoplasm.